(0.31%) 5 115.71 points
(0.40%) 38 393 points
(0.42%) 15 995 points
(-1.61%) $82.50
(4.94%) $2.02
(0.18%) $2 351.50
(0.21%) $27.59
(4.18%) $960.60
(-0.21%) $0.933
(-0.36%) $10.99
(-0.52%) $0.796
(1.69%) $93.42
Live Chart Being Loaded With Signals
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples...
Stats | |
---|---|
今日成交量 | 33.91M |
平均成交量 | 2.27M |
市值 | 396.23M |
EPS | $0 ( 2024-03-26 ) |
下一个收益日期 | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.04 |
ATR14 | $0.167 (7.95%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Taich Adam | Sell | 48 425 | Common Stock |
2024-01-05 | Taich Adam | Sell | 185 812 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 110 000 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 145 000 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 150 000 | Stock Option (Right to buy) |
INSIDER POWER |
---|
-85.54 |
Last 95 transactions |
Buy: 2 347 082 | Sell: 20 640 281 |
音量 相关性
SomaLogic, Inc. 相关性 - 货币/商品
SomaLogic, Inc. 财务报表
Annual | 2022 |
营收: | $97.67M |
毛利润: | $54.30M (55.60 %) |
EPS: | $-0.590 |
FY | 2022 |
营收: | $97.67M |
毛利润: | $54.30M (55.60 %) |
EPS: | $-0.590 |
FY | 2021 |
营收: | $81.63M |
毛利润: | $16.06M (19.68 %) |
EPS: | $-0.00100 |
Financial Reports:
No articles found.
SomaLogic, Inc.
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。